Latest Headlines

  1. WuXi NextCODE Launches New State-Of-The-Art Genetic Analysis Laboratory In U.S. With Illumina's New TruSight 500™ Assay
    3/30/2019

    WuXi NextCODE, a global genomic data and insights company, is expanding its laboratory footprint into the U.S. with the opening of a state-of-the-art, CLIA-certified and CAP-accredited genetic analysis laboratory in Woburn, Massachusetts

  2. Discovery Life Sciences Adds The HudsonAlpha Genomic Services Laboratory To Expand Scientific Capabilities
    3/29/2019

    Discovery Life Sciences™ (Discovery) announced today that it has entered into an agreement to add the Genomic Services Laboratory (GSL) of the HudsonAlpha Institute for Biotechnology, one of the world's premier gene sequencing and bioinformatics laboratories, to form a new division: HudsonAlpha Discovery

  3. Specific Diagnostics Begins Clinical Demonstrations And Testing Of The Reveal AST System
    3/29/2019

    Specific Diagnostics today announced clinical demonstrations of the Reveal AST system will be conducted at a clinical laboratory in Amsterdam during the ECCMID conference April 13-16

  4. Fluidigm Introduces The First Complete Sample-To-Answer Solution For Deep Immune Profiling By Mass Cytometry
    3/28/2019

    Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the introduction of the Maxpar® Direct™ Immune Profiling System

  5. Specific Diagnostics Achieves CARB-X Milestone And Advances Its Reveal Rapid Antibiotic Susceptibility Test For Life-Threatening Drug-Resistant Infections
    3/28/2019

    Specific Diagnostics announced today that, based on the achievement of development and testing milestones, CARB-X has proceeded with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility test (AST) instrument

  6. Proficiency Testing Programme In China Yields Positive Results
    3/28/2019

    In the wake of the success of IBBL’s international Proficiency Testing (PT) programme, a new PT programme entirely dedicated to Chinese biobanks was launched in July 2018, in an agreement between IBBL, the International Society for Biological and Environmental Repositories (ISBER) and the Biobank Branch, China Medicinal Biotech Association (BBCMBA)

  7. The European Molecular Biology Laboratory Selects HID Global’s Industry-Leading RFID Technology In New Design Standard For Cryogenic Research Equipment
    3/27/2019

    HID Global, a worldwide leader in trusted identity solutions, recently announced that the European Molecular Biology Laboratory (EMBL) in Grenoble, France has selected HID’s radio frequency identification (RFID) tags and its patented direct bonding technology for automated handling of biological samples at cryogenic temperatures of 196°C (-321° F) in liquid nitrogen

  8. ambr ® 15 Fermentation And ambr ® 250 High Throughput Systems Now Available With Integrated Online Biomass Measurement For Microbial Applications
    3/27/2019

    Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry, is introducing integrated online biomass measurement to its ambr® 15 fermentation and ambr® 250 high throughput systems for microbial applications.

  9. New Tissue Microarrays Conform With FDA Standards
    3/26/2019

    AMSBIO offers an unmatched portfolio of over 2000 tissue microarrays (TMAs), one of the best sample formats for rapid detection of cellular localization of RNA and protein expression.

  10. Breath Diagnostics, Mayo Clinic Laboratories Announce Collaboration To Develop New Diagnostic Test That Detects Lung Cancer Using Patients' Exhaled Breath
    3/26/2019

    Breath Diagnostics, Inc. and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases